港股異動丨百度集團-SW(9888.HK)漲幅擴大至逾7% 崑崙芯片2.0開始量產
格隆匯8月24日丨百度集團-SW(9888.HK)高開高走,現漲幅擴大至逾7%,報144.2港元,總市值4079億港元。百度董事長兼CEO李彥宏近日宣佈,百度第2代自研AI芯片——崑崙芯2(又稱“崑崙2”)正式量產。崑崙芯2的性能、通用性、易用性較1代產品均有顯著增強。該芯片採用7nm製程,搭載自研的第二代XPU架構,相比1代性能提升2-3倍。崑崙芯1代產品於2018年7月4日首度推出,該芯片已在數據中心等場景部署達2萬片以上,支撐着智能雲/計算中心,智慧製造,智慧醫療和智慧城市等AI應用落地。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.